- Trials with a EudraCT protocol (44)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44 result(s) found for: CD40L.
Displaying page 1 of 3.
| EudraCT Number: 2010-023103-94 | Sponsor Protocol Number: 002:CD40L | Start Date*: 2011-07-04 |
| Sponsor Name:Uppsala University | ||
| Full Title: PHASE I/IIa AdCD40L IMMUNOGENE THERAPY FOR MALIGNANT MELANOMA PATIENTS WITH DISSEMINATED DISEASE | ||
| Medical condition: malignant melanoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-000985-34 | Sponsor Protocol Number: 001:CD40L | Start Date*: 2006-06-15 |
| Sponsor Name:Clinical Immunology Division | ||
| Full Title: A Phase I-IIa Study of Dose escalating Intravesical AdCD40L instillation in Urinary Bladder Carcinoma | ||
| Medical condition: Urinary bladder cancer is an attractive target for immunostimulating gene therapy because it is sensitive for immunotherapy as demonstrated by the life-prolonging effect of bacillus Calmette-Guérin... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003733-25 | Sponsor Protocol Number: CHUBX2013/27 | Start Date*: 2014-12-03 |
| Sponsor Name:CHU de BORDEAUX | ||
| Full Title: Pilot Study related to the effect of clopidogrel on plasmatic soluble CD40 ligand during systemic lupus erythematous | ||
| Medical condition: systemic lupus erythematous | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-002541-37 | Sponsor Protocol Number: 116777 | Start Date*: 2012-08-14 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A Phase II, open label, mono-centric study to evaluate the kinetics of mRNA expression after two doses of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 in healthy BCG-primed, HIV-... | ||
| Medical condition: Healthy volunteers (Prevention of tuberculosis [TB] disease in children, adolescents and adults) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002360-28 | Sponsor Protocol Number: 104886 | Start Date*: 2005-09-13 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: An open, randomized phase I/II study to demonstrate the non inferiority in term of cellular mediated immune response between GlaxoSmithKline Biologicals influenza candidate vaccines containing vari... | ||
| Medical condition: Immunisation against influenza disease in adults aged 18-40 years and elderly population aged over 65 years (>65 years) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-004711-35 | Sponsor Protocol Number: 112147 | Start Date*: 2008-10-07 |
| Sponsor Name:GlaxoSmithKline S.A. | ||
| Full Title: Estudio de vacunación, fase III, observador ciego, aleatorizado (3:3:2), control activo, multinacional, multicéntrico para evaluar la respuesta inmune celular y humoral de la vacuna FLU NG de GSK B... | ||
| Medical condition: Inmunización frente a la gripe estacional de varones y mujeres de 65 años y mayores o de 18 a 40 años Immunization against seasonal influenza in men and woman aged 65 years and older or 18 to 40 y... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-002724-83 | Sponsor Protocol Number: iHIVARNA-01 | Start Date*: 2017-02-22 | |||||||||||
| Sponsor Name:Erasmus MC | |||||||||||||
| Full Title: A phase IIa randomized, placebo controlled, double blinded study to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral t... | |||||||||||||
| Medical condition: Chronic HIV-1 infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) ES (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-003237-32 | Sponsor Protocol Number: 107973 | Start Date*: 2006-09-18 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults previously vac... | ||
| Medical condition: Immunisation against influenza disease in an elderly population aged over 65 years | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-002680-18 | Sponsor Protocol Number: 107975 | Start Date*: 2006-08-03 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, controlled, randomized, single blind study to evaluate the immunogenicity, safety and reactogenicity of the low dose influenza vaccine adjuvanted with AS03 compared to Fluarix™ (GlaxoSm... | ||
| Medical condition: Immunization against influenza in male and female subjects aged 60 years and older. | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002145-39 | Sponsor Protocol Number: DG-031-204 | Start Date*: 2005-07-11 |
| Sponsor Name:deCODE genetics ehf. | ||
| Full Title: An open-label, randomised dose finding study to examine safety, tolerability and dose-related effects of DG-031 on inflammatory biomarkers in serum of patients with history of myocardial infarction... | ||
| Medical condition: Ischaemic heart disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IS (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-002880-29 | Sponsor Protocol Number: 110263 | Start Date*: 2007-09-13 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults (≥66 years) pre... | ||
| Medical condition: Immunization against influenza in male and female subjects aged 66 years and older. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-001928-37 | Sponsor Protocol Number: 104540 | Start Date*: 2005-09-13 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase I/II, open, controlled study in order to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals influenza candidate vaccine containing the adjuvant AS25 (FluAS25)... | ||
| Medical condition: Immunisation against influenza disease in elderly population aged over 65 years (>65 years) | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-002881-36 | Sponsor Protocol Number: 110223 | Start Date*: 2007-09-13 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults (≥67 years) pre... | ||
| Medical condition: Immunization against influenza in male and female subjects aged 67 years and older. | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-004863-69 | Sponsor Protocol Number: 108494, 108516, 108518, 108520 | Start Date*: 2006-12-22 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, single-blind, randomized, controlled, multicentre vaccination study to evaluate the safety and immune response of the GSK Biologicals Zoster vaccine, gE/AS01B, and to compare 3 doses of... | ||
| Medical condition: Primary immunization of healthy elderly subjects (60 to 69 and more than or equal to 70 years) against zoster | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) SE (Completed) CZ (Completed) NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001860-22 | Sponsor Protocol Number: CRT | Start Date*: 2007-06-04 |
| Sponsor Name:Karl Andersen | ||
| Full Title: CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment | ||
| Medical condition: Patients with chest pain at rest or minimal physical activity of at least 20 minutes duration will be considered for inclusion in this study. To be eligible, patients have to be considered of low... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IS (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002795-13 | Sponsor Protocol Number: TACRO-Omics | Start Date*: 2020-04-23 |
| Sponsor Name:Fundación de Investigación Hospital Universitario La Paz | ||
| Full Title: Identification of "omic" biomarkers and their inter and intra-individual variability that allow improvement in the individualization of tacrolimus: uncontrolled clinical trial in pediatric patients... | ||
| Medical condition: Pediatric patients with renal transplantation (under stable treatment with tacrolimus as immunosuppressant) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-005120-86 | Sponsor Protocol Number: 112077 | Start Date*: 2009-01-08 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, observer-blind, randomised, placebo-controlled, adjuvant-dose selection, multicenter prophylactic vaccination study to evaluate the immunogenicity and safety of GSK Biologicals’ herpes ... | ||
| Medical condition: Primary immunisation of subjects aged 50 years or older against herpes zoster (HZ). The study population includes healthy volunteer males and females in the age ranges: 50-59 years of age (YOA), 6... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-003236-30 | Sponsor Protocol Number: 104887 | Start Date*: 2006-09-18 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults previously vac... | ||
| Medical condition: Immunisation against influenza disease in an elderly population aged over 65 years | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-001674-80 | Sponsor Protocol Number: ARG-E04 | Start Date*: 2005-06-13 | |||||||||||
| Sponsor Name:Mitsubishi Pharma Corporation | |||||||||||||
| Full Title: A Randomised, Open, Parallel Group, Multicentre Study to Examine the Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Combination with Clopidogrel and Aspirin in Patients u... | |||||||||||||
| Medical condition: Stable coronary artery disease (CAD) or unstable angina (troponin negative, i.e. within the normal range for the study site) with low to moderate anatomic risk and a requirement for elective percut... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-022248-19 | Sponsor Protocol Number: 114825 | Start Date*: 2011-01-25 | |||||||||||
| Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
| Full Title: An open, phase II long term extension study to evaluate the immune responses to and safety of GSK Biologicals’ candidate herpes zoster vaccine, (gE/AS01B), at Months 48, 60 and 72 post-vaccination ... | |||||||||||||
| Medical condition: Evaluation of persistence of immune responses following immunisation of healthy elderly subjects (60-69 and ≥70 years) against Herpes Zoster (HZ) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) DE (Completed) NL (Completed) CZ (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
